 | Up a level |
Arenz, D., Hero, B., Eichhorst, B. F., Langer, M., Pester, L., von Tresckow, J., Vehreschild, M. J. G. and Cornely, O. A. (2014). Estimating Site Costs Prior to Conducting Clinical Trials - a Study Site Budgeting Tool. Oncol. Res. Treat., 37. S. 32 - 33. BASEL: KARGER. ISSN 2296-5262
Cornely, O. A., Vehreschild, J. J., Vehreschild, M. J. G. T., Wuerthwein, G., Arenz, D., Schwartz, S., Heussel, C. P., Silling, G., Mahne, M., Franklin, J., Harnischmacher, U., Wilkens, A., Farowski, F., Karthaus, M., Lehrnbecher, T., Ullmann, A. J., Hallek, M. and Groll, A. H. (2011). Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis. Antimicrob. Agents Chemother., 55 (12). S. 5798 - 5804. WASHINGTON: AMER SOC MICROBIOLOGY. ISSN 0066-4804
Koehler, P., Cornely, O., Arenz, D. and Mellinghoff, S. C. (2018). EQUAL aspergillosis score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis. Oncol. Res. Treat., 41. S. 207 - 209. BASEL: KARGER. ISSN 2296-5262
Koehler, P., Cornely, O. A., Arenz, D. and Mellinghoff, S. (2018). EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis. Mycoses, 61. S. 33 - 34. HOBOKEN: WILEY. ISSN 1439-0507
Koehler, P., Mellinghoff, S., Alanio, A., Arenz, D., Hoenigl, M., Lagrou, K., Lass-Floerl, C., Meis, J., Richardson, M. and Cornely, O. A. (2018). EQUAL mucormycosis score 2018: An ECMM score derived from current guidelines to measure quality of mucormycosis management in hematology. Mycoses, 61. S. 34 - 35. HOBOKEN: WILEY. ISSN 1439-0507
Koehler, P., Mellinghoff, S. C., Alanio, A., Arenz, D., Hoenigl, M., Lagrou, K., Lass-Floerl, C., Meis, J., Richardson, M. and Cornely, O. (2018). EQUAL Mucormycosis score 2018: An ECMM score derived from current gidelines to measure QUALity of mucormycosis management in hematology. Oncol. Res. Treat., 41. S. 208 - 209. BASEL: KARGER. ISSN 2296-5262